Creative Planning Inovio Pharmaceuticals, Inc. Transaction History

Creative Planning

$101 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.35 - $0.53 $122 - $185	-350 Reduced 2.43%	14,035 $7,000
Q3 2023 Nov 16, 2023	SELL	$0.38 - $0.58 $1,357 - $2,072	-3,573 Reduced 19.9%	14,385 $5,000
Q2 2023 Jul 21, 2023	SELL	$0.39 - $0.94 $6,130 - $14,774	-15,718 Reduced 46.67%	17,958 $8,000
Q1 2023 May 15, 2023	BUY	$0.79 - $1.91 $2,362 - $5,712	2,991 Added 9.75%	33,676 $27,000
Q4 2022 Feb 10, 2023	BUY	$1.41 - $2.5 $26,183 - $46,425	18,570 Added 153.28%	30,685 $47,000
Q3 2022 Nov 03, 2022	SELL	$1.66 - $2.79 $416 - $700	-251 Reduced 2.03%	12,115 $21,000
Q2 2022 Aug 15, 2022	SELL	$1.44 - $3.98 $1,272 - $3,518	-884 Reduced 6.67%	12,366 $21,000
Q1 2022 May 16, 2022	SELL	$2.97 - $5.2 $3,430 - $6,006	-1,155 Reduced 8.02%	13,250 $47,000
Q4 2021 Feb 11, 2022	SELL	$4.99 - $7.46 $6,516 - $9,742	-1,306 Reduced 8.31%	14,405 $72,000
Q3 2021 Nov 10, 2021	SELL	$7.16 - $9.69 $68,829 - $93,149	-9,613 Reduced 37.96%	15,711 $112,000
Q2 2021 Aug 04, 2021	SELL	$6.23 - $10.03 $366,996 - $590,847	-58,908 Reduced 69.94%	25,324 $235,000
Q1 2021 Apr 30, 2021	BUY	$8.81 - $16.96 $194,366 - $374,171	22,062 Added 35.49%	84,232 $782,000
Q4 2020 Jan 29, 2021	SELL	$8.5 - $12.85 $49,385 - $74,658	-5,810 Reduced 8.55%	62,170 $550,000
Q3 2020 Nov 05, 2020	BUY	$9.57 - $27.05 $21,762 - $61,511	2,274 Added 3.46%	67,980 $789,000
Q2 2020 Jul 23, 2020	BUY	$7.14 - $31.69 $281,601 - $1.25 Million	39,440 Added 150.16%	65,706 $1.77 Million
Q1 2020 May 05, 2020	BUY	$2.98 - $14.09 $28,730 - $135,841	9,641 Added 57.99%	26,266 $195,000
Q4 2019 Jan 30, 2020	SELL	$1.97 - $3.72 $788 - $1,488	-400 Reduced 2.35%	16,625 $55,000
Q2 2019 Jul 26, 2019	BUY	$2.29 - $4.1 $38,987 - $69,802	17,025 New	17,025 $50,000
Q1 2019 Apr 24, 2019	SELL	$3.34 - $5.1 $37,247 - $56,875	-11,152 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$3.89 - $6.11 $1,672 - $2,627	-430 Reduced 3.71%	11,152 $45,000
Q2 2018 Jul 20, 2018	SELL	$3.88 - $5.16 $15,182 - $20,191	-3,913 Reduced 25.25%	11,582 $45,000
Q1 2018 Apr 18, 2018	BUY	$4.05 - $5.69 $21,870 - $30,726	5,400 Added 53.49%	15,495 $73,000
Q4 2017 Jan 17, 2018	BUY	$4.13 - $6.68 $41,692 - $67,434	10,095	10,095 $42,000

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $476M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account